Our results are consistent with these findings and we have demonstrated that eNOS is a key mediator for GPR87 in the regulation of metastatic properties through the AKT-eNOS-NO signaling pathway in lung adenocarcinoma. Here, AKT1 is linked to lung adenocarcinoma.